Zoetis Inc. (ZTS)

NYSE: ZTS · USD

$75.4

+0.78 (+1.1%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-27 02:00 UTC. Latest published research analyzed 2026-05-12 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh ZTS analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-12

Our latest published analysis: ZTS rated Strong Buy

Strong Buy. Extreme market dislocation implies structural decay, vastly underestimating the 22.7% ROIC and companion animal inelasticity.

Fair value (mid)

$140 / share

$109 – $170

Upside to FV

+81.7%

from $75.4

Confidence

88/100

Moat

9/10

Read full analysis

Market cap	$32.3B
Revenue (ttm)	9.5B
Net income (ttm)	2.7B
EPS (ttm)	$6.11
Shares out	419.2M
P/E (trailing)	12.3x
P/E (forward)	10.3x
Dividend	$2.12 (2.81%)
Volume	5,198,136
Beta	0.75
Price target	$114	+51.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.5B
Net income (ttm): 2.7B
EPS (ttm): $6.11
P/E (trailing): 12.3x
P/E (forward): 10.3x
Market cap: $32.3B

Item	P1	P2	P3	P4	Trend
Period	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$8.08B	$8.54B	$9.26B	$9.47B	+5.4%
Gross profit	$5.63B	$5.98B	$6.54B	$6.80B	+6.5%
Operating income	$2.93B	$3.07B	$3.39B	$3.60B	+7.1%
Net income	$2.11B	$2.34B	$2.49B	$2.67B	+8.1%
EPS (diluted)	$4.49	$5.07	$5.47	$6.02	+10.3%
EBITDA	$3.34B	$3.67B	$3.86B	$4.07B	+6.8%
R&D	$539.0M	$614.0M	$686.0M	$698.0M	+9.0%
SG&A	$2.01B	$2.15B	$2.32B	$2.38B	+5.8%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	41.0x	11.0x	104.3%	+6.8%	+58.6%	Sell
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
ADBE	Adobe Inc.	104.7B	15.1x	4.2x	60.7%	+11.9%	-28.7%	Strong Buy
ABBV	AbbVie Inc.	465.2B	129.7x	7.4x	14.4%	+4.6%	+44.0%	Hold
ABT	Abbott Laboratories	186.9B	34.9x	4.0x	7.9%	+3.0%	-12.5%	Strong Buy
AMGN	Amgen Inc.	209.2B	27.0x	5.6x	19.1%	+8.1%	+32.5%	Strong Buy

All ZTS indicators

Market & fundamental data

Available fields

283

Groups with data

Currency

USD

Showing 283 of 283 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001555280
Company name	Zoetis Inc.
Country	United States
Country code	US
Cusip	98978V103
Employees	14,500
Employees Change	700%
Employees Change Percent	5.07
Enterprise value	$38.9B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	126.3
Industry PE Fwd	14.06
IPO Date	2013-02-01
Isin	US98978V1035
Last refreshed	2026-07-27
Market cap	$31.6B
Market cap category	Large-Cap
Price	$75.35
Price currency	USD
Rev Per Employee	657,310.34x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	2834
Symbol	ZTS
Website	https://www.zoetis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.46%
EV Earnings	14.56x
EV Sales Forward	3.95x
EV/EBIT	11.11x
EV/EBITDA	9.76x
EV/FCF	17.39x
EV/Sales	4.08x
FCF yield	7.08%
Forward P/E	10.81x
P/B ratio	9.8x
P/E ratio	12.34x
P/S ratio	3.31x
PE Ratio10 Y	36.43x
PE Ratio3 Y	30.21x
PE Ratio5 Y	34.84x
PEG ratio	1.5x
PS Forward	3.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	36.81%
EBITDA Margin	41.93%
FCF margin	23.47%
Gross margin	71.84%
Gross Profit	$6.8B
Gross Profit Growth	4.18%
Gross Profit Growth Q	2.59%
Gross Profit Growth3 Y	6.75%
Gross Profit Growth5 Y	7%
Net Income	$2.7B
Net Income Growth	7.35%
Net Income Growth Q	-0.17%
Net Income Growth Years	10%
Net Income Growth3 Y	8.86%
Net Income Growth5 Y	8.54%
Pretax Margin	35.1%
Profit Margin	28.03%
Profit Per Employee	$184,276
Profitable Quarters	$43
Profitable Years	16
ROA	15.52
Roa5y	13.76
ROCE	26.72
ROE	67.75
Roe5y	52.61
ROIC	27.8
Roic5y	28.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.05%
Cagr1y	-49.98%
Cagr3y	-24.65%
Cagr5y	-17.1%
Div CAGR10	18.97%
Div CAGR3	12.96%
Div CAGR5	17.08%
EPS Growth	11.01
EPS Growth Q	5.97
EPS Growth Quarters	7
EPS Growth Years	10
EPS Growth3 Y	11.4
EPS Growth5 Y	10.48
FCF Growth	2.62%
FCF Growth Q	-13.65%
FCF Growth3 Y	15.34%
FCF Growth5 Y	5.87%
OCF Growth	-2.89%
OCF Growth Q	-22.14%
OCF Growth10 Y	15.59%
OCF Growth3 Y	9.04%
OCF Growth5 Y	5.67%
Revenue Growth	2.88x
Revenue Growth Q	2.91x
Revenue Growth Quarters	41x
Revenue Growth Years	10x
Revenue Growth3 Y	5.6x
Revenue Growth5 Y	6.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.65
Assets	$15.2B
Cash	$1.9B
Current Assets	$6.5B
Current Liabilities	$2.1B
Debt	$9.3B
Debt EBITDA	$2.32
Debt Equity	$2.86
Debt FCF	$4.14
Equity	$3.2B
Interest Coverage	15.22
Liabilities	$11.9B
Long Term Assets	$8.7B
Long Term Liabilities	$9.9B
Net Cash	$-7.3B
Net Cash By Market Cap	$-23.15
Net Debt EBITDA	$1.83
Net Debt Equity	$2.26
Net Debt FCF	$3.27
Tangible Book Value	$-504M
Tangible Book Value Per Share	$-1.2
WACC	6.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.15
Inventory Turnover	1.09
Net Working Capital	$2.5B
Quick ratio	1.68
Working Capital	$4.4B
Working Capital Turnover	$2.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.25%
Dividend Growth	8.18%
Dividend Growth Years	12%
Dividend per share	$2.12
Dividend Years	14
Dividend Yield	2.81%
Ex Div Date	2026-07-20
Last Dividend	$0.53
Payout Frequency	Quarterly
Payout Ratio	34.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	63.66%
1Y total return	-49.95%
200-day SMA	112.1
3Y total return	-57.22%
50-day SMA	77.08
50-day SMA vs 200-day SMA	50under200
5Y total return	-60.85%
All Time High	249.3
All Time High Change	-69.77%
All Time High Date	2021-12-30
All Time Low	28.14
All Time Low Change	167.82%
All Time Low Date	2014-04-15
ATR	2.34
Beta	0.75
Beta1y	0.55
Beta2y	0.36
Ch YTD	-40.11
High	76.06
High52	160.5
High52 Date	2025-08-20
High52ch	-53.05%
Low	74.28
Low52	71.47
Low52 Date	2026-06-30
Low52ch	5.43%
Ma50ch	-2.25%
Premarket Change Percent	0.64
Premarket Price	$75.05
Premarket Volume	1,036
Price vs 200-day SMA	-32.78%
RSI	45.26
RSI Monthly	26.36
RSI Weekly	26.4
Sharpe ratio	-1.83x
Sortino ratio	-1.94
Total Return	6.07%
Tr YTD	-39.17
Tr1m	-1.26%
Tr1w	-0.89%
Tr3m	-34.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	20
Analyst Count Top	6
Analyst Price Target Top	$103
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$1.86
Earnings EPS Estimate Growth	5.68
Earnings Revenue Estimate	2,511,409,424x
Earnings Revenue Estimate Growth	0.46x
Operating Income	$3.6B
Operating Income Growth	6.32
Operating Income Growth Q	0.98
Operating Income Growth3 Y	8.11
Operating Income Growth5 Y	7.64
Operating margin	38.12
Price target	$114
Price Target Change	$51.06
Price Target Change Top	$37.23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	418,375,367%
Float Percent	99.8%
Net Borrowing	2,311,000,000
Shares Insiders	0.09%
Shares Institutions	99.31%
Shares Out	419,228,118
Shares Qo Q	-3.69%
Shares Yo Y	-3.25%
Short Float	3.81%
Short Ratio	2.15
Short Shares	3.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.1B
Average Volume	6,342,468.7x
Bv Per Share	7.69
CAPEX	$-553M
Ch10y	49.92
Ch1m	-1.94
Ch1w	-1.58
Ch1y	-50.9
Ch3m	-35.08
Ch3y	-58.94
Ch5y	-62.99
Ch6m	-39.26
Change	1.05%
Change From Open	0.31
Close	74.57
Days Gap	0.74
Depreciation Amortization	441,000,000
Dollar Volume	391,679,547.6
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$3.5B
EBITDA	$4B
EPS	$6.11
F Score	7
FCF	$2.2B
FCF EV Yield	5.75x
FCF Per Share	$5.34
Financing CF	-2,033,000,000
Fiscal Year End	December
Founded	1,952
Goodwill	2,778,000,000
Graham Number	32.50873
Graham Upside	-56.86
Income Tax	$673M
Investing CF	-632,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-12
Lynch Fair Value	$52.13
Lynch Upside	-30.81
Ma150	106
Ma150ch	-28.93%
Ma20	74.95
Ma20ch	0.53%
Net CF	148,000,000
Next Earnings Date	2026-08-06
Open	75.12
Optionable	Yes
P FCF Ratio	14.12
P OCF Ratio	11.32
Payment Date	2026-09-01
Position In Range	60.11
Post Close	75.35
Postmarket Change Percent	0.78
Postmarket Price	$75.94
Ppne	4,001,000,000
Pre Close	74.57
Price Date	2026-07-24
Price EBITDA	$7.92
Relative Volume	0.82x
Revenue	9,531,000,000x
SBC By Revenue	0.95x
Share Based Comp	91,000,000
Tax By Revenue	7.06x
Tax Rate	20.12%
Tr6m	-38.57%
Us State	New Jersey
Views	83
Volume	5,198,136
Z Score	6.21

Frequently asked questions

About this ZTS report

What is the latest published ZTS stock rating?

Zoetis Inc. is shown with strong buy in the latest published report, analyzed 2026-05-12. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ZTS analysis?

The full latest published report, analyzed 2026-05-12, lives at /stocks/ZTS/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for ZTS?

The latest published report analyzed 2026-05-12 frames ZTS around USD 109 to USD 170. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the ZTS page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-12). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Zoetis Inc. (ZTS)

Coverage state: Latest published research available

Generate a fresh ZTS analysis

Our latest published analysis: ZTS rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ZTS

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All ZTS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ZTS

Frequently asked questions